Related Experiment Video
Updated: May 5, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
IL-18 production is required for the generation of a Th1 response during experimental chromoblastomycosis
Lucas Golçalves Ferreira1, Sandro Rogério de Almeida1
1School of Pharmaceutical Sciences, Department of Clinical e Toxicological Analysis, University of São Paulo, São Paulo, Brazil.
Insights
Interleukin-18 (IL-18) is crucial for controlling fungal loads in chromoblastomycosis. This cytokine activates Th1 cells, enhancing the immune response against the fungal infection.
Area of Science:
- Immunology
- Mycology
- Infectious Diseases
Background:
- Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissues.
- A cell-mediated immune response, particularly Th1 responses, is essential for protection.
- Interleukin-18 (IL-18) induces Interferon-gamma (IFNγ), a key cytokine in Th1 cell activation.
Purpose of the Study:
- To investigate the role of IL-18 in chromoblastomycosis immunity.
- To elucidate the mechanisms by which IL-18 influences the host response to fungal infection.
Main Methods:
- Detection of fungal presence and host immune response markers.
- Analysis of inflammasome activation (NLRP3, caspase-1) and cytokine production (IL-18, IFNγ).
- Assessment of Th1 cell activation and fungal load in experimental models.
Main Results:
- The fungus Fonsecaea pedrosoi activates the NLRP3 inflammasome, leading to caspase-1 activation and IL-18 production.
- IL-18 is critical for the activation of Th1 cells.
- IL-18 contributes significantly to controlling fungal loads during chromoblastomycosis.
Conclusions:
- IL-18 plays a vital role in the immune defense against chromoblastomycosis by promoting Th1 cell responses.
- Targeting IL-18 mediated pathways could offer novel therapeutic strategies for chromoblastomycosis.
Abstract:
Chromoblastomycosis is a chronic fungal infection characterized by the formation of granulomatous lesions in the skin and subcutaneous tissues that begins after inoculation trauma. The disease is more frequently observed in tropical countries such as Brazil. Important studies have been shown a predominantly cell-mediated immune response during chromoblastomycosis. Results from our laboratory showed that Th1 responses are essential to induce protection during chromoblastomycosis. IL-18 is primarily produced by macrophages and is known to induce the production of IFNγ, a cytokine associated with Th1 cell activation. Once produced, IL-18 acts to promote Th1 cell differentiation and activation. Th1 cells, in turn, secrete cytokines such as IFNγ, which are critical for the elimination of intracellular pathogens, including fungi. IFNγ enhances the fungicidal activity of macrophages, promotes the development of antifungal effector mechanisms, and contributes to the containment of fungal growth. Our results indicate that F. pedrosoi is sensed by the NLRP3 inflammasome, which induces caspase-1 activation and production of IL-18. Moreover, IL-18 plays a crucial role in activating Th1 cells and controlling fungal loads during chromoblastomycosis. Further research into the mechanisms underlying IL-18-mediated immunity may lead to the development of novel therapeutic approaches for the treatment of this chronic fungal infection.

